Acute exposure to aluminium dust impairs lung function.
Contact with other fibrotic brokers could be excluded. Researchers figured using HRCT was even more sensitive than standard chest X-rays for the recognition of early-stage aluminum-dust-induced lung disease. While inconclusive, there was enough evidence to claim that further research of the phenomenon was warranted. Outcomes 50 years in the making A half-hundred years ago, researchers suspected that pulmonary fibrosis and encephalopathy were linked to the inhalation of light weight aluminum dust even. A 1962 research examined the scientific, radiographic, pathological, and environmental features of a case of intensive aluminium fibrosis of the lung area are reported in a man of 49 years who had worked for 13 1/2 years in the ball-mill space of an aluminium powder factory, the abstract mentioned.– January 29, 2010: Publication in the February 2010 issue of the Journal of Clinical Tumor Research of positive Phase 2 results for perifosine as a single agent for the treating advanced Waldenstrom’s macroglobulinemia. February 3 -, 2010: Special Protocol Evaluation granted by the United States Food and Drug Administration for the Phase 3 trial of perifosine in combination with capecitabine ) in refractory advanced colorectal cancers. The trial is usually to be executed by Keryx Biopharmaceuticals, Inc. , Aeterna Zentaris’ partner and licensee for perifosine in North America.